神经护理小组的ITBS抑郁治疗协议 得到了FDA批准 阿波罗 TMS治疗系统。 Neurocare Group's iTBS protocol for depression treatment received FDA clearance for the Apollo TMS Therapy System.
心理健康创新领导者 Neurocare Group 的间歇性 Theta 爆发刺激 （iTBS） 协议获得了 FDA 的批准，该协议可用于 Apollo TMS 治疗系统和其他经颅磁刺激 （TMS） 系统。 Neurocare Group, a mental health innovation leader, received FDA clearance for its Intermittent Theta Burst Stimulation (iTBS) protocol, available across the Apollo TMS Therapy System and other Transcranial Magnetic Stimulation (TMS) systems. iTBS协议为抑郁症治疗提供更有效、一致的刺激力,每次治疗需要3分钟,并涵盖口服抗抑郁症后的主要抑郁症病例。 The iTBS protocol offers a more efficient, consistent delivery of stimulation power for depression treatment, requiring 3 minutes per session, and covers major depression cases after oral antidepressant failure. 阿波罗 TMS 治疗系统 由FDA批准 保险覆盖 The Apollo TMS Therapy system is FDA-cleared and insured-covered.